I think alot of LT holders share the same testament. The minimum annaul revenue of $40m is an outstanding base to be sitting on all while we have a lot to look forward to!
Im sure we will be hearing a few ANN's regarding the below in the not to distant future:
- GMP Certification
- Commercialisation of API Products
- RMIT cannabis research initiatives
- Phase 2A epilepsy clinical study
- Production and sales of medical grade product for the treatment of Epilepsy
- Results from breeding and genetic program to treat medical conditions including epilepsy and chionic pain.
- Results from sales from wholesaler reseller retail outlets for MGC Derma range in Spain, Italy, Romania and Romania
- Results and sales from distribution agreement with Lenis, MXC supplying Cannabis Flower and CannEpil in Central and Eastern Europe.
I think its fair to say with the media jumping on MXC's outstanding result on Friday, there is a good chance there will be alot of people wanting to get in on MXC come monday morning!
Add to My Watchlist
What is My Watchlist?
